Fundación Pública Galega de Medicina Xenómica (SERGAS). Centro Nacional de Genotipado. Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain; Faculty of Health Sciences, Universidad Autónoma de Chile, Talca, Chile.
Fundación Pública Galega de Medicina Xenómica (SERGAS). Centro Nacional de Genotipado. Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain; Grupo de Medicina Xenómica- CIMUS- Universidade de Santiago de Compostela, Santiago de Compostela, Spain; Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
Trends Immunol. 2023 Oct;44(10):754-756. doi: 10.1016/j.it.2023.08.011. Epub 2023 Sep 9.
Research on human leukocyte antigen (HLA) molecules in coronavirus disease 2019 (COVID-19) raised high expectations but has yielded limited results. Augusto et al.'s recent study in Nature unveils a strong association of HLA-B*15:01 with asymptomatic COVID-19, representing an important contribution to genetics in COVID-19.
针对 2019 年冠状病毒病（COVID-19）的人类白细胞抗原（HLA）分子的研究寄予厚望，但结果有限。奥古斯托等人最近在《自然》杂志上的研究揭示了 HLA-B*15:01 与无症状 COVID-19 之间的强烈关联，这是 COVID-19 遗传学的重要贡献。
